Abstract
With the continuous growth in human population, rising incidence and predominance of various diseases, there is growing need for development of natural as well as engineered diagnostic systems and drugs in order to meet the therapeutic demands. Since microorganisms have evolved in nature with an astounding set of mechanisms utilized in detecting and responding to varied, transient and enduring external stimuli, such microbial systems can be utilized in diagnosis as well as giving competition to animal cells in producing value added products due to its easy and low cost processing. The re-making of various biosensing systems by incorporating whole cells intend to provide efficient biological detection and measurable response. Microbes governing the synthesis of biopolymers are also found to be exploited in developing new generation of novel drug delivery systems and as repair material of tissues. The area of synthetic biology together with novel microbial systems and whole cells is gaining rapid attention in diagnostics and global health challenges. With this background, the present chapter highlights various applications of microbes in pharmaceutical industries with special emphasis on diagnosis and drug delivery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Lateff A, Klemke C, König GM, Wright AD (2003) Two new xanthone derivatives from the algicolous marine fungus Wardomycesanomalus. J Nat Prod 66:706–708
Abdel-Lateff A, König GM, Fisch KM, Höller U, Jones PG, Wright AD (2005) New antioxidant hydroquinone derivatives from the algicolous marine fungus Acremonium sp. J Nat Prod 65:1605–1611
Aumiller JJ, Hollister JR, Jarvis DL (2003) A transgenic insect cell line engineered to produce CMP–sialic acid and sialylated glycoproteins. Glycobiology 13(6):497–507
Ballio A, Bossa F, Collina A, Gallo M, Iacobellis NS, Paci M, Pucci P, Scaloni A, Segre A, Simmaco M (1990) Structure of syringotoxin, a bioactive metabolite of Pseudomonas syringaepv. syringae. FEBS Lett 269:377–380
Bleckwenn NA, Shiloach J (2004) Large-scale cell culture. Curr Protoc Immunol. A-1U
Borowitzka MA, Borowitzka LJ (1988) Micro-algal biotechnology. Cambridge University Press, New York
Buss AD, Waigh RD (1995) Natural products as leads for new pharmaceuticals. In: Wolff ME (ed) Burger’s medicinal chemistry and drug discovery. Principles and practice, vol 1. Wiley, New York, pp 983–1033
Castillo UF, Strobel GA, Ford EJ, Hess WM, Porter H, Jensen JB, Albert H, Robison R, Condron MA, Teplow DB, Stevens D (2002) Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedianigriscansa. Microbiology 148:2675–2685
Castillo UF, Strobel GA, Mullenberg K, Condron MM, Teplow DB, Folgiano V, Gallo M, Ferracane R, Mannina L, Viel S, Codde M (2006) Munumbicins E-4 and E-5: novel broad-spectrum antibiotics from Streptomyces NRRL 3052. FEMS Microbiol Lett 255:296–300
Christina A, Christapher V, Bhore SJ (2013) Endophytic bacteria as a source of novel antibiotics: an overview. Pharm Rev. 2013 7:11
Davidson SK, Allen SW, Lim GE, Anderson CM, Haygood MG (2001) Evidence for the biosynthesis of bryostatins by the bacterial symbiont “CandidatusEndobugulasertula” of the bryozoan Bugula neritina. Appl Environ Microbiol 67:4531–4537
Devine DA, Marsh PD (2009) Prospects for the development of probiotics and prebiotics for oral applications. J Ora Micro 1:1949
Du J, Shao Z, Zhao H (2011) Engineering microbial factories for synthesis of value-added products. J Indu Microbiol Biotech 38:873–890
Feling RH, Buchanan GO, Mincer TJ, Kauffman CA, Jensen PR, Fenical W (2003) Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew Chem Int Ed Eng 42:355–357
Ghosh G, Bachas LG, Anderson KW (2008) Biosensor incorporating cell barrier architectures on ion selective electrodes for early screening of cancer. Anal Bioanal Chem 391:2783–2791
Harrigan GG, Yoshida WY, Moore RE, Nagle DG, Park PU, Biggs J, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA (1998) Isolation, structure determination, and biological activity of dolastatin and lyngbyastatin 1 from Lyngbyamajuscula/Schizothrixcalcicola cyanobacterial assemblages. J Nat Prod 61:1221–1225
Harrison L, Teplow DB, Rinaldi M, Strobel G (1991) Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity. Microbiology 137:2857–2865
Hidalgo-Bastida LA, Barry JJA, Everitt NM, Rose FRAJ, Buttery LD, Hall IP, Claycomb WC, Shakesheff KM (2007) Cell Adhesion and mechanical properties of a flexible scaffold for cardiac tissue engineering. Acta Biomaterialia 3:457–462
Hoffmann S, Maculloch B, Batz M (2015) Economic burden of major foodborne illnesses acquired in the United States. USDA-140. GPO, Washimhton, DC
Hollister JR, Jarvis DL (2001) Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian β1, 4-galactosyltransferase and α2, 6-sialyltransferase genes. Glycobiology 11(1):1–9
Hollister J, Grabenhorst E, Nimtz M, Conradt H, Jarvis DL (2002) Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 41(50):15093–15104
Ivnitski D, Abdel-Hamid I, Atanasov P, Wilkins E (1999) Biosensors for detection of pathogenic bacteria. Biosens Bioelectron 14(7):599–624
Jenkins N (2007) Modifications of therapeutic proteins: challenges and prospects. Cytotechnology 53(1–3):121–125
Kim EJ, Cho SH, Yuk SH (2001) Polymeric microspheres composed of pH/temperature- sensitive polymer complex. Biomaterials 22:2495–2499
Kintzios SE (2007) Cell-based biosensors in clinical chemistry. Mini-Rev Med Chem 7:1019–1026
Kurkuri MD, Aminabhavi TM (2004) Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine. J Control Release 96:9–20
Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH (2001) Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J Nat Prod 64:610–907
Manning MC, Patel K, Borchardt RT (1989) Stability of protein pharmaceuticals. Pharm Res 6(11):903–918
Marienhagen J, Bott M (2013) Metabolic engineering of microorganisms for the synthesis of plant natural products. J Biotechnol 163:166–178
Martin O, Averous L (2001) Poly (Lactic acid): plasticization and properties of biodegradable multiphase systems. Polymer 42:6209–6219
Masci G, Bontempo D, Crescenzi V (2002) Synthesis and characterization of thermoresponsive N-isopropylacrylamide/methacrylated pullulan hydrogels. Polymer 43:5587–5593
Mihai D, Mocanu G, Carpov A (2001) Chemical reactions on polysaccharides: I. Pullulan sulfation. Eur Polym J 37:541–546
Miller CM, Miller RV, Garton-Kenny D, Redgrave B, Sears J, Condron MM, Teplow DB, Strobel GA (1998) Ecomycins, unique antimycotics from Pseudomonas viridiflava. J Appl Microbiol 84:937–944
Misra SK, Valappil SP, Roy I, Boccaccini AR (2006) Polyhydroxyalkanoate (PHA) inorganic Ohase composites for tissue engineering applications. Biomacromolecules 7:2249–2258
Mohan C, Kim YG, Koo J et al (2008) Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells. Biotechnol J 3(5):624–630
Nakagawa A, Minami H, Kim JS, Koyanagi T, Katayama T, Sato F, Kumagai H (2011) A bacterial platform for fermentative production of plant alkaloids. Nat Commun 2:326
Nissim A, Chernajovsky Y (2008) Historical development of monoclonal antibody therapeutics. In: Therapeutic antibodies. Springer, Berlin, pp 3–18
Rogers KR, Gerlach CL (1999) An update on environmental biosensors. Environ Sci Technol 33(23):500A–506A
Rechnitz GA, Kobos RK, Riechel SJ, Gebauer CR (1977) A bio-selective membrane electrode prepared with living bacterial cells. Anal Chim Acta 94:357–365
Redwan ERM (2007) Cumulative updating of approved biopharmaceuticals. Hum Antibodies 16:137–158
Sinclair AM, Elliott S (2005) Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 94(8):1626–1635
Struss PP, Ensor CM, Raut N, Daunert S (2010) Paper strip whole cell biosensors: a portable test for the semi quantitative detection of bacterial quorum signaling molecules. Anal Chem 82:4457–4463
Su L, Jia W, Hou C, Lei Y (2011) Microbial biosensors: a review. Biosens Bioelectron 26:1788–1799
Trindade-Silva AE, Lim-Fong GE, Sharp KH, Haygood MG (2010) Bryostatins: biological context and biotechnological prospects. Curr Opin Biotechnol 21:780–786
Wang X, Liu M, Wang X, Wu Z, Yang L, Xia S, Chen L, Zhao J (2013) p-Benzoquinone-mediated amperometric biosensor developed with Psychrobacter sp. for toxicity testing of heavy metals. Biosens Bioelectron 41:557–562
Walsh G, Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24(10):1241–1252
Wang J, Guleria S, Koffas MA, Yan Y (2016) Microbial production of value-added nutraceuticals. Curr Opin Biotechnol 37:97–104
Zhao J, Li Q, Sun T, Zhu X, Xu H, Tang J, Zhang X, Ma Y (2013) Engineering central metabolic modules of Escherichia coli for improving β-carotene production. Meta Eng 17:42
Acknowledgement
The authors are thankful to Director, MNNIT Allahabad for providing necessary research facilities and acknowledge the support of MHRD sponsored project “Design and Innovation Centre” and Centre for Medical Diagnostic and Research (CMDR), MNNIT Allahabad.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mishra, M. et al. (2018). Exploring the Multifaceted Role of Microbes in Pharmacology. In: Patra, J., Das, G., Shin, HS. (eds) Microbial Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-10-7140-9_15
Download citation
DOI: https://doi.org/10.1007/978-981-10-7140-9_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7139-3
Online ISBN: 978-981-10-7140-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)